- Trials with a EudraCT protocol (287)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
287 result(s) found for: Amyloid.
Displaying page 1 of 15.
EudraCT Number: 2018-002548-10 | Sponsor Protocol Number: CAAAMY | Start Date*: 2019-10-10 | ||||||||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | ||||||||||||||||||
Full Title: PET/MRI study of amyloid burden in patients with Cerebral Amyloid Angiopathy-related inflammation | ||||||||||||||||||
Medical condition: cerebral amyloid angiopathy related inflammation (CAA-ri) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000219-15 | Sponsor Protocol Number: 13-10 | Start Date*: 2014-11-27 |
Sponsor Name:VU Medical Center | ||
Full Title: Amyloid pathology in cognitively normal elderly subjects | ||
Medical condition: Cognitively healthy elderly, aged 60-100 years old. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002527-21 | Sponsor Protocol Number: AMYPAD-01 | Start Date*: 2018-05-23 |
Sponsor Name:University of Geneva | ||
Full Title: Multicentre, Open-label, Randomised Study to Assess the Diagnostic Value of Amyloid PET Imaging in Patients with Subjective Cognitive Decline Plus, Mild Cognitive Impairment, or Dementia Where Alzh... | ||
Medical condition: Alzheimer's disease Mild Cognitive Impairment Subjective Cognitive Decline Plus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) DE (Completed) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001586-27 | Sponsor Protocol Number: SOMCT01-C | Start Date*: 2014-07-25 | |||||||||||
Sponsor Name:SOM Innovation Biotech SL (SOM Biotech) | |||||||||||||
Full Title: Study of SOM0226 in familial amyloid polyneuropathy (FAP) patients and asymptomatic carriers to evaluate protein stabilization activity | |||||||||||||
Medical condition: Patients with familial amyloid polyneuropathy (FAP), asymptomatic carriers and healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004466-34 | Sponsor Protocol Number: 18-07 | Start Date*: 2019-05-16 |
Sponsor Name:Amsterdam UMC VUmc | ||
Full Title: Tau PET imaging in cognitively normal elderly subjects: A twin approach | ||
Medical condition: Cognitively healthy elderly, aged 60-100 years old. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005115-13 | Sponsor Protocol Number: ISIS420915-CS4 | Start Date*: 2018-04-25 | |||||||||||
Sponsor Name:Ionis Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Non-Interventional Study to Monitor the Survival Status of Patients that Discontinued from ISIS 420915-CS2 or ISIS 420915-CS3 | |||||||||||||
Medical condition: Familial Amyloid Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) FR (Ongoing) GB (Completed) PT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003877-40 | Sponsor Protocol Number: ALN-TTR02-006 | Start Date*: 2015-05-11 | ||||||||||||||||
Sponsor Name:Alnylam Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients with Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Clinical Study ... | ||||||||||||||||||
Medical condition: Transthyretin mediated amyloidosis (ATTR) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) SE (Completed) PT (Ongoing) DE (Completed) NL (Completed) GB (GB - no longer in EU/EEA) CY (Completed) IT (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001831-30 | Sponsor Protocol Number: ISIS420915-CS2 | Start Date*: 2013-04-22 | |||||||||||
Sponsor Name:Ionis Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients with Familial Amyloid Polyneuropathy | |||||||||||||
Medical condition: Familial Amyloid Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) PT (Completed) DE (Completed) IT (Completed) ES (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004244-28 | Sponsor Protocol Number: BAN2401-G000-303 | Start Date*: 2023-04-17 | |||||||||||
Sponsor Name:Eisai Ltd. | |||||||||||||
Full Title: AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel Treatment Arm, 216 Week Study with an Extension Phase to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Prec... | |||||||||||||
Medical condition: Preclinical Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001066-16 | Sponsor Protocol Number: H23750 | Start Date*: 2007-01-04 |
Sponsor Name:John L. Berk, M.D. | ||
Full Title: The effect of diflunisal (IND 68092) on familial amyloidosis | ||
Medical condition: Familial Amyloid Polyneuropathy (FAP) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) IT (Ongoing) GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004561-13 | Sponsor Protocol Number: ISIS420915-CS3 | Start Date*: 2014-07-04 | |||||||||||
Sponsor Name:Ionis Pharmaceuticals, Inc | |||||||||||||
Full Title: An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 420915 in Patients with Familial Amyloid Polyneuropathy (FAP) | |||||||||||||
Medical condition: Familial Amyloid Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) GB (GB - no longer in EU/EEA) DE (Completed) FR (Completed) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011535-12 | Sponsor Protocol Number: Fx1A-303 | Start Date*: 2009-08-26 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients with Transthyretin Amyloidosis | |||||||||||||
Medical condition: Transthyretin Amyloidosis (ATTR) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SE (Completed) FR (Completed) PT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002987-17 | Sponsor Protocol Number: ALN-TTR02-004 | Start Date*: 2013-11-25 | ||||||||||||||||
Sponsor Name:Alnylam Pharmaceuticals, Inc | ||||||||||||||||||
Full Title: APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran (ALN-TTR02) in Transthyretin (TTR)-Mediated Polyneu... | ||||||||||||||||||
Medical condition: Transthyretin mediated amyloidosis (ATTR) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) ES (Completed) PT (Completed) IT (Completed) DE (Completed) NL (Completed) GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002603-29 | Sponsor Protocol Number: ALN-TTRSC-005 | Start Date*: 2015-12-01 | |||||||||||
Sponsor Name:Alnylam Pharmaceuticals, Inc | |||||||||||||
Full Title: An Open-Label Study To Evaluate The Efficacy And Safety Of Revusiran In Patients With Transthyretin-Mediated Familial Amyloidotic Polyneuropathy With Disease Progression Post Orthotopic Liver Trans... | |||||||||||||
Medical condition: Transthyretin (TTR)-mediated Familial Amyloidotic Polyneuropathy (FAP) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) PT (Completed) ES (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020724-21 | Sponsor Protocol Number: ADR16SUS2 | Start Date*: 2011-04-06 |
Sponsor Name:Universitätsklinik für Neurologie, Medizinische Universität Wien | ||
Full Title: Amyloid Imaging with [11C]PIB PET and MRI in MCI – a pilot study | ||
Medical condition: Patients with Mild Cognitive Impairment (MCI) will be investigated with PIB PET to determin amyloid pathology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004670-10 | Sponsor Protocol Number: AG10-333 | Start Date*: 2020-07-07 | |||||||||||
Sponsor Name:Eidos Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Polyneuropathy (ATTRibute-PN Trial) | |||||||||||||
Medical condition: Symptomatic Transthyretin Amyloid Polineuropathy (ATTR-PN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) DE (Prematurely Ended) PT (Prematurely Ended) FR (Completed) BG (Prematurely Ended) NL (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004627-16 | Sponsor Protocol Number: 70233 | Start Date*: 2020-11-25 | |||||||||||
Sponsor Name:Helsinki University Hospital | |||||||||||||
Full Title: Clinical Validation of Quantitative Flutemetamol PET/CT in Cardiac Amyloidosis | |||||||||||||
Medical condition: Cardiac amyloidosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-018064-95 | Sponsor Protocol Number: S52151 | Start Date*: 2012-06-18 |
Sponsor Name:University of Leuven | ||
Full Title: Amyloid imaging in late life depression | ||
Medical condition: Late life depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002277-22 | Sponsor Protocol Number: AMYPAD-02 | Start Date*: 2018-09-12 |
Sponsor Name:Stichting VUmc | ||
Full Title: AMYPAD Prognostic and Natural History Study (PNHS), an open label, prospective, multicentre, cohort study in individuals without dementia to evaluate the additional value of quantitative amyloid im... | ||
Medical condition: Alzheimer's Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) ES (Completed) BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001262-87 | Sponsor Protocol Number: Fx-006 | Start Date*: 2008-07-04 | |||||||||||
Sponsor Name:FoldRx Pharmaceuticals, Inc. | |||||||||||||
Full Title: An Open-Label Extension of Study Fx-005 Evaluating Long-Term Safety and Clinical Outcomes of Fx-1006A in Patients with Transthyretin Amyloid Polyneuropathy | |||||||||||||
Medical condition: Transthyretin Amyloid Polyneuropathy (ATTR-PN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) SE (Completed) FR (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.